By Adam Bonislawski
New York University researchers presented data at last week's American Association for Cancer Research annual meeting in Orlando, Fla., on a study using Somalogic's Somamer technology for the detection of protein biomarkers for malignant mesothelioma.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.